510(k) K190851

HYDRASHIFT 2/4 daratumumab by Sebia — Product Code CFF

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 2, 2019
Date Received
April 2, 2019
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Immunoelectrophoretic, Immunoglobulins, (G, A, M)
Device Class
Class II
Regulation Number
866.5510
Review Panel
IM
Submission Type